Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Chongqing Medical UniversityActive in the last 2 years

Xing Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4014-7037; OpenAlex author ID A5101645274. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. High-Intensity Focused Ultrasound Ablation Combined With Pharmacogenomic-Guided Chemotherapy for Advanced Pancreatic Cancer: Initial Experience. Co-author DOI 10.1016/j.ultrasmedbio.2024.06.013↗
  2. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis. Co-author DOI 10.18632/oncotarget.18091↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kun Zhou · 1 shared paper, 2024 · strength 0.24
  2. Chengbing Jin · 1 shared paper, 2024 · strength 0.24
  3. Lifeng Ran · 1 shared paper, 2024 · strength 0.24
  4. Jun Zhang · 1 shared paper, 2024 · strength 0.24
  5. Geng Liu · 1 shared paper, 2017 · strength 0.09
  6. Kaiqiang Wang · 1 shared paper, 2017 · strength 0.09
  7. Jinjin Sun · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.